Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H. Dougados M, et al. Among authors: van der heijde d. Arthritis Rheum. 2001 Jan;44(1):180-5. doi: 10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K. Arthritis Rheum. 2001. PMID: 11212158 Free article. Clinical Trial.
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.
Gossec L, van der Heijde D, Melian A, Krupa DA, James MK, Cavanaugh PF, Reicin AS, Dougados M. Gossec L, et al. Among authors: van der heijde d. Ann Rheum Dis. 2005 Nov;64(11):1563-7. doi: 10.1136/ard.2004.029611. Epub 2005 Feb 24. Ann Rheum Dis. 2005. PMID: 15731291 Free PMC article. Clinical Trial.
Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists.
Gossec L, Dougados M, Phillips C, Hammoudeh M, de Vlam K, Pavelka K, Pham T, Braun J, Sieper J, Olivieri I, van der Heijde D, Collantes E, Stone M, Kvien TK; ASAS (ASsessment in AS international working group). Gossec L, et al. Among authors: van der heijde d. Ann Rheum Dis. 2008 Jun;67(6):782-8. doi: 10.1136/ard.2007.080077. Epub 2007 Nov 29. Ann Rheum Dis. 2008. PMID: 18055468 Free PMC article.
Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative.
Dougados M, Leclaire P, van der Heijde D, Bloch DA, Bellamy N, Altman RD. Dougados M, et al. Among authors: van der heijde d. Osteoarthritis Cartilage. 2000 Nov;8(6):395-403. doi: 10.1053/joca.2000.0361. Osteoarthritis Cartilage. 2000. PMID: 11069723 Free article. Review.
A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis.
Sieper J, van der Heijde D, Dougados M, Maksymowych WP, Scott BB, Boice JA, Berd Y, Bergman G, Curtis S, Tzontcheva A, Huyck S, Weng HH. Sieper J, et al. Among authors: van der heijde d. Arthritis Rheumatol. 2015 Oct;67(10):2702-12. doi: 10.1002/art.39257. Arthritis Rheumatol. 2015. PMID: 26139307 Free PMC article. Clinical Trial.
1,101 results